Psychiatry Medical News about Schizophrenia

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. Omega-3 fatty acids for bipolar disorder

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Beneficial effects of N- acetylcysteine in treatment resistant schizophrenia
World Journal of Biological Psychiatry, 09/21/09

Bulut M et al. – Poor response to antipsychotics is still an important problem in the treatment of many schizophrenia patients. N–Acetylcysteine (NAC) is a compound that exerts anti–oxidant and scavenging actions against reactive oxygen species. This article reports a case of poorly responsive schizophrenia patient who improved considerably with add–on NAC 600 mg/day. The NAC might work through activating cysteine–glutamate antiporters or reducing in nitric oxide (NO) metabolites, free radicals and cytokines or through both of these mechanisms.

<< Previous
Opioid use affects antioxidant activity and purine metabolism:...

Next >>
Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid...

Auditory gating deficit to human voices in schizophrenia: A MEG study
Schizophrenia Research, 10/01/09 Relevance Score: 93%

Age at onset and cognition in schizophrenia: meta-analysis
British Journal of Psychiatry, 10/06/09 Relevance Score: 92%

Beyond symptom dimensions: Schizophrenia risk factors for patient groups derived by latent class analysis
Schizophrenia Research, 10/30/09 Relevance Score: 91%

Functional Magnetic Resonance Imaging of Inner Speech in Schizophrenia
Biological Psychiatry, 10/26/09 Relevance Score: 91%

Sensory Processing in Schizophrenia: Neither Simple nor Intact
Schizophrenia Bulletin, 10/19/09 Relevance Score: 91%